Add to ORKGAccelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design
Developing a vaccine against the human immunodeficiency virus (HIV) poses an exceptional challenge. ...
Accelerating clinical development of HIV vaccine proportion, without direct comparisons between arms...
Item does not contain fulltextHIV infection leads to a gradual loss CD4+ T lymphocytes comprising im...
International audienceBACKGROUND: Many candidate vaccine strategies against human immunodeficiency v...
International audienceBACKGROUND: Many candidate vaccine strategies against human immunodeficiency v...
International audienceBACKGROUND: Many candidate vaccine strategies against human immunodeficiency v...
International audienceBACKGROUND: Many candidate vaccine strategies against human immunodeficiency v...
International audienceBACKGROUND: Many candidate vaccine strategies against human immunodeficiency v...
Despite major advances in HIV-1 therapeutics and prevention strategies, the development of a safe an...
International audienceHIV vaccine strategies are expected to be a crucial component for controlling ...
Development of an effective AIDS vaccine is a global priority. However, the extreme diversity of HIV...
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to i...
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to i...
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to i...
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to i...
Developing a vaccine against the human immunodeficiency virus (HIV) poses an exceptional challenge. ...
Accelerating clinical development of HIV vaccine proportion, without direct comparisons between arms...
Item does not contain fulltextHIV infection leads to a gradual loss CD4+ T lymphocytes comprising im...
International audienceBACKGROUND: Many candidate vaccine strategies against human immunodeficiency v...
International audienceBACKGROUND: Many candidate vaccine strategies against human immunodeficiency v...
International audienceBACKGROUND: Many candidate vaccine strategies against human immunodeficiency v...
International audienceBACKGROUND: Many candidate vaccine strategies against human immunodeficiency v...
International audienceBACKGROUND: Many candidate vaccine strategies against human immunodeficiency v...
Despite major advances in HIV-1 therapeutics and prevention strategies, the development of a safe an...
International audienceHIV vaccine strategies are expected to be a crucial component for controlling ...
Development of an effective AIDS vaccine is a global priority. However, the extreme diversity of HIV...
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to i...
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to i...
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to i...
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to i...
Developing a vaccine against the human immunodeficiency virus (HIV) poses an exceptional challenge. ...
Accelerating clinical development of HIV vaccine proportion, without direct comparisons between arms...
Item does not contain fulltextHIV infection leads to a gradual loss CD4+ T lymphocytes comprising im...